Skip to content

EVONIK OXENO ANTWERPEN NV

Active
Public limited companyfounded 200125 yrs activeTijsmanstunnel-West 0, 2040 Antwerpen, BelgiumKBO/BCE: BE 0474.062.952
Summary

EVONIK OXENO ANTWERPEN NV has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (€-11.56M) and a net result of €-37.85M. Its solvency ranks better than 5% of 267 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Watch
Print / PDF

Checked score

Score 2025
44 / 100
Weak
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Negative equity caps the score. Every signal that weighs is under Signals.
Axes
Profitability0
Solvency17
Growth-
Track record85
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity ample (current ratio 2.26; short-term debt: 38.6% of total assets), but equity is negative.
How do we compute the score and the probability?
Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 20
Relative position
BE, all sectors
reference
Sector 20
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 25 years 0 30 y
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-05-2026, 66 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
66 d early
2024
59 d early
2023
49 d early
2022
77 d early
2021
53 d early
2020
72 d early
2019
37 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, full schema

Turnover
€605.48M
EBIT margin
-6.5%
Net result
€-37.85M
Working capital
€69.06M
Balance-sheet composition
Assets €142.24M
Fixed assets €18.34M
Current assets €123.90M
Key figures and ratios
2025 value
EBITDA
€-34.78M
Cash flow
€-33.11M
Solvency
-8.1%
Current ratio
2.26
Quick ratio
1.78
Debt to equity
-4.74
ROA
-26.6%
Interest coverage
-141.42
Debt
€54.84M
Debt ≤ 1 year
€54.84M
Income taxes
€72k
Staff costs
€14.48M
Filed annual accounts As filed with the NBB · 2025 · 72 lines
Balance sheet Code2025
Assets
Total assets20/58€142.24M
Fixed assets21/28€18.34M
Tangible fixed assets22/27€18.34M
Land and buildings22€6.23M
Plant, machinery and equipment23€9.82M
Furniture and vehicles24€38k
Assets under construction and advance payments27€2.26M
Current assets29/58€123.90M
Stocks and contracts in progress3€26.35M
Stocks30/36€26.35M
Raw materials and consumables30/31€6.21M
Finished goods33€20.14M
Amounts receivable within one year40/41€36.98M
Trade receivables40€35.08M
Other amounts receivable41€1.90M
Current investments50/53€60.44M
Other investments51/53€60.44M
Deferred charges and accrued income490/1€117k
Equity and liabilities
Total equity and liabilities10/49€142.24M
Equity10/15€-11.56M
Contributions10/11€5.00M
Capital10€5.00M
Issued capital100€5.00M
Reserves13€500k
Non-distributable reserves130/1€500k
Legal reserve130€500k
Profit (loss) carried forward14€-17.06M
Provisions and deferred taxes16€98.96M
Provisions for liabilities and charges160/5€98.96M
Pensions and similar obligations160€147k
Other liabilities and charges164/5€98.81M
Amounts payable17/49€54.84M
Amounts payable within one year42/48€54.84M
Trade debts44€45.52M
Suppliers440/4€45.52M
Taxes, remuneration and social security45€3.70M
Taxes450/3€1.09M
Remuneration and social security454/9€2.61M
Other amounts payable47/48€5.62M
Accrued charges and deferred income492/3€5k
Income statement Code2025
Operating income70/76A€589.39M
Turnover70€605.48M
Change in stocks of work in progress, finished goods and contracts in progress71€-20.36M
Own construction capitalised72€164k
Other operating income74€4.11M
Operating charges60/66A€628.92M
Goods for resale, raw materials and consumables60€473.34M
Purchases600/8€472.43M
Change in stocks: decrease (increase)609€906k
Services and other goods61€120.39M
Remuneration, social security and pensions62€14.48M
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4.75M
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€309k
Provisions for liabilities and charges: additions (uses and reversals)635/8€15.30M
Other operating charges640/8€345k
Operating profit (loss)9901€-39.52M
Financial income75/76B€8.05M
Recurring financial income75€8.05M
Income from current assets751€2.14M
Other financial income752/9€5.91M
Financial charges65/66B€6.30M
Recurring financial charges65€6.30M
Debt charges650€246k
Other financial charges652/9€6.06M
Profit (loss) for the period before taxes9903€-37.78M
Income taxes67/77€72k
Taxes670/3€72k
Profit (loss) for the period9904€-37.85M
Profit (loss) for the period to be appropriated9905€-37.85M
Appropriation of the result
Profit (loss) to be appropriated9906€-17.06M
Profit (loss) brought forward from the previous period14P€20.79M
Social balance
Average headcount (FTE)908793.4

The notes to these accounts (65 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
26-05
NBB filing Annual accounts filed
fiscal year 2025 · full schema
10-02
State Gazette act Resignation: Tim Vermeiren (permanent representative)
Appointment: Christophe Van Parys (permanent representative)3 facts ▸
  • General meeting, 12-02-2025
  • Director resignation, Tim Vermeiren (permanent representative)
  • Director appointment, Christophe Van Parys (permanent representative)
2025
02-06
NBB filing Annual accounts filed
fiscal year 2024 · full schema
2024
21-11
State Gazette act Reappointment: KPMG Bedrijfsrevisoren BV/SRL (statutory auditor)
Permanent representative: Tim VERMEIREN3 facts ▸
  • General meeting, 03-05-2024
  • Auditor reappointment, KPMG Bedrijfsrevisoren BV/SRL (statutory auditor)
  • Permanent representative, Tim VERMEIREN (statutory auditor)
05-07
State Gazette act Algemene Vergadering
Statutes amendment · Capital4 facts ▸
  • General meeting, 02-07-2024
  • Statutes amendment
  • Statutes amendment
  • Capital, €5.000.000
12-06
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
30-06
State Gazette act Resignations: Ivan PELGRIMS, Maurizio FINOTTO and Bart VAN ROIE
Appointments: Wim MELLAERTS (director) and Koen VERMEIREN (director) · Mandate compensation · Power of attorney12 facts ▸
  • General meeting, 05-05-2023
  • Director resignation, Ivan PELGRIMS (bestuurder, afgevaardigd bestuurder, voorzitter van de raad van bestuur)
  • Director resignation, Maurizio FINOTTO (director)
  • Director resignation, Bart VAN ROIE (director)
  • Director appointment, Wim MELLAERTS (director)
  • Director appointment, Koen VERMEIREN (director)
  • Mandate compensation, Wim MELLAERTS
  • Mandate compensation, Koen VERMEIREN
  • Board meeting, 05-05-2023
  • Director appointment, Wim MELLAERTS (afgevaardigd bestuurder)
  • Board meeting, 07-06-2023
  • Power of attorney, Ivan PELGRIMS
15-05
NBB filing Annual accounts filed
fiscal year 2022 · full schema
2022
08-06
NBB filing Annual accounts filed
fiscal year 2021 · full schema
02-06
State Gazette act Reappointment: Ivan PELGRIMS (director)
Appointment: Ivan PELGRIMS (chair of the board) · Mandate compensation8 facts ▸
  • General meeting, 06-05-2022
  • Board meeting, 06-05-2022
  • Director reappointment, Ivan PELGRIMS (director)
  • Mandate compensation, Ivan PELGRIMS
  • Director appointment, Ivan PELGRIMS (chair of the board)
  • Mandate compensation, Ivan PELGRIMS
  • Director reappointment, Ivan PELGRIMS (afgevaardigd bestuurder)
  • Director appointment, Ivan PELGRIMS (day-to-day manager)
2021
26-05
State Gazette act Resignation: Jean Paul Palmans (director)
Appointments: Maurizio Finotto (director) and Bart Van Roie (director) · Mandate compensation6 facts ▸
  • General meeting, 11-03-2021
  • Director resignation, Jean Paul Palmans (director)
  • Director appointment, Maurizio Finotto (director)
  • Mandate compensation, Maurizio Finotto
  • Director appointment, Bart Van Roie (director)
  • Mandate compensation, Bart Van Roie
26-05
State Gazette act Resignation: PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)
Appointments: KPMG Bedrijfsrevisoren BV/SRL (statutory auditor) and Ivan PELGRIMS (chair of the board) · Permanent representative: Tim VERMEIREN · Director discharge9 facts ▸
  • General meeting, 07-05-2021
  • Board meeting, 07-05-2021
  • Director resignation, PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)
  • Director discharge, PricewaterhouseCoopers Bedrijfsrevisoren
  • Director discharge, Bart VAN GOMPEL
  • Auditor appointment, KPMG Bedrijfsrevisoren BV/SRL (statutory auditor)
  • Permanent representative, Tim VERMEIREN
  • Director appointment, Ivan PELGRIMS (chair of the board)
  • Mandate compensation, Ivan PELGRIMS
Show earlier events
20-05
NBB filing Annual accounts filed
fiscal year 2020 · full schema
2020
22-07
State Gazette act Reappointment: PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)
Permanent representatives: Bart VAN GOMPEL and Peter VAN DEN EYNDE4 facts ▸
  • General meeting, 19-06-2020
  • Auditor reappointment, PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Bart VAN GOMPEL
  • Permanent representative, Peter VAN DEN EYNDE
24-06
NBB filing Annual accounts filed
fiscal year 2019 · full schema
17-04
State Gazette act Appointment: PwC Bedrijfsrevisoren (statutory auditor)
Permanent representatives: Bart VAN GOMPEL, Peter VAN DEN EYNDE and BVBA Peter Van den Eynde · Resignation: Willy GOYVAERTS (statutory auditor)6 facts ▸
  • General meeting, 23-01-2020
  • Auditor appointment, PwC Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Bart VAN GOMPEL
  • Director resignation, Willy GOYVAERTS (statutory auditor)
  • Permanent representative, Peter VAN DEN EYNDE
  • Permanent representative, BVBA Peter Van den Eynde
2019
13-08
State Gazette act Resignations: Joachim Dahm (director) and Axel Matthes (director)
Appointment: Jean Paul Palmans (director) · Mandate compensation5 facts ▸
  • General meeting, 13-06-2019
  • Director resignation, Joachim Dahm (director)
  • Director resignation, Axel Matthes (director)
  • Director appointment, Jean Paul Palmans (director)
  • Mandate compensation, Jean Paul Palmans
15-05
NBB filing Annual accounts filed
fiscal year 2018 · full schema
23-04
State Gazette act Resignation: Rainer FRETZEN (director and chair of the board)
Appointment: Joachim DAHM (director) · Director discharge · Mandate compensation7 facts ▸
  • General meeting, 18-03-2019
  • Director resignation, Rainer FRETZEN (director and chair of the board)
  • Director discharge, Rainer FRETZEN
  • Director appointment, Joachim DAHM (director)
  • Mandate compensation, Joachim DAHM
  • Director appointment, Joachim DAHM (chair of the board)
  • Mandate compensation, Joachim DAHM
2018
28-05
NBB filing Annual accounts filed
fiscal year 2017 · full schema
22-05
State Gazette act Reappointments: Rainer FRETZEN, Jörg MATTHES and Frank DAMAN
Appointments: Ivan PELGRIMS, Rainer FRETZEN and Frank DAMAN · Resignation: Frank DAMAN (bestuurder en afgevaardigd bestuurder) · Mandate compensation15 facts ▸
  • General meeting, 26-04-2018
  • Board meeting, 26-04-2018
  • Director reappointment, Rainer FRETZEN (director)
  • Director reappointment, Jörg MATTHES (director)
  • Director reappointment, Frank DAMAN (director)
  • Director appointment, Ivan PELGRIMS (director)
  • Director appointment, Rainer FRETZEN (chair of the board)
  • Director appointment, Frank DAMAN (afgevaardigd bestuurder)
  • Director resignation, Frank DAMAN (bestuurder en afgevaardigd bestuurder)
  • Director appointment, Ivan PELGRIMS (afgevaardigd bestuurder)
  • Mandate compensation, Rainer FRETZEN
  • Mandate compensation, Jörg MATTHES
  • +3 further facts in this act
05-03
State Gazette act Reappointments: PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor) and Willy GOYVAERTS (statutory auditor)
Permanent representative: Peter VAN DEN EYNDE · Power of attorney5 facts ▸
  • General meeting, 27-04-2017
  • Auditor reappointment, PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)
  • Auditor reappointment, Willy GOYVAERTS (statutory auditor)
  • Permanent representative, Peter VAN DEN EYNDE
  • Power of attorney, BVBA Peter Van den Eynde
2017
13-06
NBB filing Annual accounts filed
fiscal year 2016 · full schema
2014
09-05
State Gazette act Reappointments: Rainer FRETZEN, Jörg MATTHES and 2 others
Permanent representatives: Willy GOYVAERTS and Peter VAN DEN EYNDE · Appointments: Rainer FRETZEN (chair of the board) and Frank DAMAN (afgevaardigd bestuurder) · Mandate compensation14 facts ▸
  • General meeting, 24-04-2014
  • Director reappointment, Rainer FRETZEN (director)
  • Director reappointment, Jörg MATTHES (director)
  • Director reappointment, Frank DAMAN (director)
  • Mandate compensation, Rainer FRETZEN
  • Mandate compensation, Jörg MATTHES
  • Mandate compensation, Frank DAMAN
  • Auditor reappointment, PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Willy GOYVAERTS
  • Permanent representative, Peter VAN DEN EYNDE
  • Board meeting, 24-04-2014
  • Director appointment, Rainer FRETZEN (chair of the board)
  • +2 further facts in this act
11-02
State Gazette act Resignation: Stefan KROLL (bestuurder en afgevaardigd bestuurder)
Appointment: Frank DAMAN (director)5 facts ▸
  • General meeting, 26-11-2013
  • Board meeting, 26-11-2013
  • Director resignation, Stefan KROLL (bestuurder en afgevaardigd bestuurder)
  • Director appointment, Frank DAMAN (director)
  • Director appointment, Frank DAMAN (afgevaardigd bestuurder)
2012
01-10
State Gazette act Resignation: Josef METZ (director and chair of the board)
Appointment: Rainer FRETZEN (director) · Director discharge6 facts ▸
  • General meeting, 19-07-2012
  • Director resignation, Josef METZ (director and chair of the board)
  • Director discharge, Josef METZ
  • Director appointment, Rainer FRETZEN (director)
  • Board meeting, 19-07-2012
  • Director appointment, Rainer FRETZEN (chair of the board)
06-07
State Gazette act Resignation: Udo PETERS (director)
Appointment: PwC Bedrijfsrevisoren (statutory auditor) · Permanent representative: Peter VAN DEN EYNDE · Director discharge6 facts ▸
  • General meeting, 26-04-2012
  • Director resignation, Udo PETERS (director)
  • Director discharge, Udo PETERS
  • Auditor appointment, PwC Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Peter VAN DEN EYNDE
  • Mandate term, eindigt gelijktijdig met de Gewone Algemere Vergadering der Aandeelhouders van het jaar 2014
2011
19-07
State Gazette act Reappointment: PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)
2 facts ▸
  • General meeting, 09-05-2011
  • Auditor reappointment, PricewaterhouseCoopers Bedrijfsrevisoren (statutory auditor)
2010
01-10
State Gazette act Resignation: Dr. Lutz HIPPE (bestuurder en afgevaardigd bestuurder)
Appointment: Stefan KROLL (director) · Mandate compensation6 facts ▸
  • General meeting, 13-09-2010
  • Board meeting, 13-09-2010
  • Director resignation, Dr. Lutz HIPPE (bestuurder en afgevaardigd bestuurder)
  • Director appointment, Stefan KROLL (director)
  • Mandate compensation, Stefan KROLL
  • Director appointment, Stefan KROLL (afgevaardigd bestuurder)
03-06
State Gazette act Reappointments: Dr. Josef METZ, Dr. Udo PETERS and 2 others
Appointment: Dr. Josef METZ (chair of the board) · Mandate compensation13 facts ▸
  • General meeting, 29-04-2010
  • Board meeting, 29-04-2010
  • Director reappointment, Dr. Josef METZ (director)
  • Director reappointment, Dr. Udo PETERS (director)
  • Director reappointment, Jörg MATTHES (director)
  • Director reappointment, Dr. Lutz HIPPE (director)
  • Mandate compensation, Dr. Josef METZ
  • Mandate compensation, Dr. Udo PETERS
  • Mandate compensation, Jörg MATTHES
  • Mandate compensation, Dr. Lutz HIPPE
  • Director appointment, Dr. Josef METZ (chair of the board)
  • Mandate compensation, Dr. Josef METZ
  • +1 further facts in this act
2009
23-03
State Gazette act Resignation: Jan Van den Bergh (bestuurder voorzitter)
Appointment: METZ Josef Ernst (director) · Statutes amendment · Director discharge7 facts ▸
  • General meeting, 10/03/2009
  • Statutes amendment
  • Director resignation, Jan Van den Bergh (bestuurder voorzitter)
  • Director discharge, Jan Van den Bergh
  • Director appointment, METZ Josef Ernst (director)
  • Mandate compensation, METZ Josef Ernst
  • Power of attorney, Van Impe Hans
2006
29-12
State Gazette act Reappointments: Dr. Detlef ARNOLDI, Jörg MATTHES and 2 others
Mandate compensation13 facts ▸
  • General meeting, 31-03-2006
  • Board meeting, 31-03-2006
  • Director reappointment, Dr. Detlef ARNOLDI (director)
  • Director reappointment, Jörg MATTHES (director)
  • Director reappointment, Dr. Udo PETERS (director)
  • Director reappointment, Jan VAN DEN BERGH (director)
  • Mandate compensation, Dr. Detlef ARNOLDI
  • Mandate compensation, Jörg MATTHES
  • Mandate compensation, Dr. Udo PETERS
  • Mandate compensation, Jan VAN DEN BERGH
  • Director reappointment, Dr. Detlef ARNOLDI (chair of the board)
  • Mandate compensation, Dr. Detlef ARNOLDI
  • +1 further facts in this act
2005
07-06
State Gazette act Resignation: Dr. Helmut KRETSCHMER (director)
Appointment: Axel Jorg MATTHES (director) · Meeting extract · Mandate compensation5 facts ▸
  • General meeting, 20-12-2004
  • Meeting extract, 20-12-2004
  • Director resignation, Dr. Helmut KRETSCHMER (director)
  • Director appointment, Axel Jorg MATTHES (director)
  • Mandate compensation, Axel Jorg MATTHES
07-06
State Gazette act Resignation: Klynveld Peat Marwick goerdeler-Bedrijfsrevisoren BCV (statutory auditor)
Appointment: PricewaterhouseCoopers Bedrijfsrevisoren bovba (statutory auditor) · Auditor discharge4 facts ▸
  • General meeting, 31-03-2005
  • Auditor resignation, Klynveld Peat Marwick goerdeler-Bedrijfsrevisoren BCV (statutory auditor)
  • Auditor discharge, dankt de Heer Luc OEYEN voor detijdens de uitoefening van zijn mandaat aan de vennootschap bewezen diensten
  • Auditor appointment, PricewaterhouseCoopers Bedrijfsrevisoren bovba (statutory auditor)
State Gazette actNBB filing

Directors · office · real estate

Directors
6 directors, no change since 2023
Koen VERMEIREN
Director · since 01-07-2023
Current
Wim MELLAERTS
Director · since 01-07-2023
Current
Jörg MATTHES
Director · since 31-03-2006
Not recently confirmed
METZ Josef Ernst
Director · since 01-01-2009
Not recently confirmed
Dr. Detlef ARNOLDI
Director · since 31-03-2006
Not recently confirmed
Axel Jorg MATTHES
Director · since 01-01-2005
Not recently confirmed
01-10-2025 Christophe Van Parys: Appointed as Permanent representative
01-10-2025 Tim Vermeiren: Resigned as Permanent representative
01-07-2023 Koen VERMEIREN: Appointed as Director
01-07-2023 Wim MELLAERTS: Appointed as Director
01-07-2023 Wim MELLAERTS: Appointed as Afgevaardigd bestuurder
Full history in the Timeline (61 changes) →
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2001
establishment approximate The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Tijsmanstunnel-West 02040 Antwerpen
1 establishment unit
OXENO ANTWERPEN NV
Frans Tijsmanstunnel 0, 2040 AntwerpenNACE 2413003
since 20012.131.861.050

Statutory auditor

1 auditor
KPMG Bedrijfsrevisoren BV/SRLCurrent
Statutory auditor · represented by Tim VERMEIREN
07-05-2021 → present
Show 3 earlier auditors
PricewaterhouseCoopers Reviseurs d'Entreprises
Statutory auditor · represented by Bart VAN GOMPEL
31-03-2005 → 07-05-2021
Pwc Bedrijfsrevisoren
Statutory auditor · represented by Bart VAN GOMPEL
succeeded by KPMG Bedrijfsrevisoren BV/SRL in 2021
01-01-2020 → 07-05-2021
Willy GOYVAERTS
Statutory auditor
27-04-2017 → 23-01-2020

Articles of association

Purpose
De productie, de verwerking en verkoop van scheikundige producten, inzonderheid van C4-producten en hun derivaten met inbegrip van alle productiefasen, onderzoek en ontwikkeling…
Full purpose

De productie, de verwerking en verkoop van scheikundige producten, inzonderheid van C4-producten en hun derivaten met inbegrip van alle productiefasen, onderzoek en ontwikkeling, alsmede alle met het voorwerp van de vennootschap in verband staande verrichtingen.

according to the deed of 05-07-2024

Structure & network

Connections & network

5 connected companies
Evonik Antwerpen, 5 shared directors EAEvonikAntwerpenFEDERATION BELGE DES INDUSTRIES CHIMIQUES ET DES SCIENCES DE LA VIE, 5 shared directors FBFEDERATIONBELGE DES…Federation of Belgian Industrial Energy Consumers, 3 shared directors FOFederation ofBelgian…INDAVER, Shared director IINDAVERVANDEPUTTE MEDICAL, Shared director VMVANDEPUTTEMEDICALEVONIK OXENO ANTWERPEN NV EVONIK OXENOANTWERPEN NV0474.062.952
Shared directors
Linked via shared directors
Show 1 more companies with a shared director
VANDEPUTTE MEDICAL
Shared director
→

Ownership & control

1 parent company
Control over this companyparent company per the LEI register1
Evonik Industries AG
Essen, Germany
controls
EVONIK OXENO ANTWERPEN NVBE 0474.062.952

Capital and shareholders

Capital over the years
  1. 05-07-2024 Capital stated in the act · 5,000,000 EUR · 10,000 shares

Public money · subsidies and aid

Flemish government

2024 · 2 entries · 6,674 EUR awarded · 6,674 EUR paid
Year Entries awardedpaid
2024 2 6,674 EUR6,674 EUR
Schemes
Vlaams opleidingsverlof (VOV)
1 entry · 5,474 EUR · 5,474 EUR paid · Departement Werk en Sociale Economie
Premie kwalificerend werkplekleren
1 entry · 1,200 EUR · 1,200 EUR paid · Departement Werk en Sociale Economie

Recognitions · licences · registrations

Dual-learning approval

2 live approvals · 1 ended
Chemische procestechnieken duaal (so)
Goedgekeurd · 2023 to 2028
Productiemedewerker industrie duaal (so)
Goedgekeurd · 2023 to 2028
Show 1 ended approval
Basisoperator proceschemie (so)
discontinued · 2023 to 2025

Legal Entity Identifier

529900IWK9ICB8WXKW34
live in the LEI register

Similar companies · same sector, comparable size

Vynova AO Belgium
BE 0849.813.337
Tessenderlo-Ham · FTE 87.1
CABOT PLASTICS BELGIUM
BE 0406.902.231
Ans · FTE 101.6
Corden Pharma Brussels
BE 0430.891.915
Elsene · FTE 84.3
Vibrantz Minerals
BE 0403.045.985
Saint-Ghislain · FTE 80.5
UMICORE SPECIALTY MATERIALS BRUGGE
BE 0405.150.984
Brugge · FTE 118.8
Of 107 companies in sector 20140 we hold annual accounts for 93. 69 are within a factor 10 of this headcount. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formPublic limited company
Founded12-02-2001
Fiscal year end31-12
Activities, NACEBEL 2025
20140Manufacture of chemicals and chemical products
46851Wholesale of industrial chemicals
46460Wholesale of pharmaceutical and medical goods
Sources
Crossroads Bank for EnterprisesNational Bank · 24 filings

Scores and ratios are computed by Checked and are not a credit decision.

We would like to set cookies. That happens only with your consent. What we measure